实体瘤疗效评价标准
医学
医学物理学
放射科
疾病
进行性疾病
内科学
作者
Lawrence H. Schwartz,Saskia Litière,Elisabeth G.E. de Vries,Robert Ford,Stephen J. Gwyther,Sumithra J. Mandrekar,Lalitha Shankar,Jan Bogaerts,Alice Chen,Janet Dancey,Wendy Hayes,F. Stephen Hodi,Otto S. Hoekstra,Erich P. Huang,Nancy U. Lin,Yan Liu,Patrick Therasse,Jedd D. Wolchok,Lesley Seymour
标识
DOI:10.1016/j.ejca.2016.03.081
摘要
Abstract
The Response Evaluation Criteria in Solid Tumours (RECIST) were developed and published in 2000, based on the original World Health Organisation guidelines first published in 1981. In 2009, revisions were made (RECIST 1.1) incorporating major changes, including a reduction in the number of lesions to be assessed, a new measurement method to classify lymph nodes as pathologic or normal, the clarification of the requirement to confirm a complete response or partial response and new methodologies for more appropriate measurement of disease progression. The purpose of this paper was to summarise the questions posed and the clarifications provided as an update to the 2009 publication.
科研通智能强力驱动
Strongly Powered by AbleSci AI